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Recurrent waves of spreading depolarization (SD) spontaneously occur minutes after the onset of focal ischemia in the brain and keep 
generating for a number of days to follow. It has become widely accepted that ischemia-related SDs are part of the pathophysiology of 
cerebrovascular diseases and predict worse outcome. SDs may exacerbate ischemic injury via related atypical hemodynamic responses. 
The incidence of ischemic stroke is known to increase markedly with age; yet, very few studies investigated whether age alters SD 
evolution and whether a potential age-specific pattern of SD would contribute to the age-related intensification of infarct development. 
Experimental data demonstrate that aging has a marked impact on SD evolution and corresponding changes in cerebral blood flow. We 
hypothesize that an age-specific pattern of the SD-associated hemodynamic response must be involved in augmenting the expansion 
of ischemic brain damage in the elderly patients and that structural and functional (mal)adaptation of the cerebrovascular system 
with aging serves as a potential basis for compromised vascular reactivity and subsequent tissue damage. The concept put forward is 
expected to stimulate further investigation to achieve a comprehensive overview of the implication of SD in injury progression in the 
aged brain.
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BRAIn injury as a result of stroke can have devastating effects on the patients’ quality of life and imposes a 
heavy burden on the health care system. The resultant neu-
rological deficit obviously depends not only upon the sever-
ity and nature of the initial injury but also upon secondary 
and progressive deleterious events, such as spreading depo-
larization (SD). Research on SD considerably accelerated 
in the last decade, in part because SD has been directly and 
consistently shown to occur in the injured human brain 
(1,2). SD has been recognized as a potent pathogenic phe-
nomenon that contributes to the progression of ischemic 
brain injury, and it has become increasingly clear that the 
occurrence of SD predicts worse clinical outcome from 
neurological casualties (3,4). Based on accumulating evi-
dence, monitoring SD has been proposed as a potential 
tool to help design the optimal intervention and therapeutic 
strategy in neurological intensive care (1).
Clinical investigation of SD is limited due to ethical 
issues, the unpredictability of SD events, and the restricted 
range of methods that can be applied in a clinical setting. 
Accordingly, it is highly relevant to explore the neurode-
generative mechanisms of SD and cerebrovascular pathol-
ogy in animal models. The early phase of ischemia may be 
of special interest because the early SD events that evolve 
shortly after the onset of an ischemic insult typically escape 
detection in patients due to the lag between injury onset and 
admission to a health care unit or the start of data acquisi-
tion. Thus, complementary data obtained from clinical and 
experimental studies will promote our understanding of 
the pathogenic role SD plays in cerebrovascular diseases. 
Accordingly, the current review presents experimental and 
clinical findings side-by-side for the direct comparison, 
integration, and translation of results.
The incidence of ischemic stroke is known to increase 
markedly with age; yet, experimental studies examining 
the role of SD in lesion progression are conventionally car-
ried out with young adult laboratory animals. The reasons 
for this are likely convenience related: young animals are 
easy to obtain, tolerate surgical intervention reasonably, 
mortality rates are low, and fewer animals are required to 
produce data that are relatively uniform with acceptable 
variation within experimental groups. Yet, the suitabil-
ity of young animal models for stroke has been the target 
of recent debate within the scientific community because 
it has become widely acknowledged that observations 
made in young animals may not be directly translated to 
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human cerebrovascular disease states (5). This applies for 
SD research as well, where appropriate, aged animal mod-
els are needed to elucidate the exact contribution of SD to 
injury progression in elderly stroke patients.
With the present review, we wish to raise awareness that 
the age-related alteration of SD evolution may be a symp-
tom or possibly a factor contributing to the escalation of 
ischemic brain injury in the elderly patients. Because data 
concerning the impact of age on the pattern of SD is sparse, 
the topic addressed here may encourage investigators to 
focus on features of SD evolution typical of the aging brain. 
This, then, may offer relevant information to better under-
stand the etiology and pathomechanisms of cerebrovascular 
diseases in elderly patients.
Spreading Depolarization Evolves in the 
Ischemic Brain: Pathogenic Potential
Cortical SD is a wave of intense, synchronized depolari-
zation of a critical mass of neurons and glia cells, which 
propagates across the cerebral cortex at a rate of 2–6 mm/
min (6,7). SD can be experimentally initiated in the oth-
erwise physiologically intact cortex by the topical appli-
cation of high-concentration potassium, local electrical 
stimulation, or focal mechanical insult (7). High concen-
tration in extracellular potassium and glutamate also medi-
ate the feedforward depolarization event as it propagates 
across gray matter (7). Regarded originally an experimental 
curiosity, spontaneously generating SD has proven to be 
a potent pathogenic phenomenon in neurological diseases 
such as migraine with aura, subarachnoid hemorrhage, trau-
matic brain injury, and ischemic stroke (1,8).
Recurrent waves of SD spontaneously occur minutes after 
the onset of focal ischemia in the rat brain (9,10), whereas 
single SD events typically evolve within the first hour after 
global forebrain insults (11). A primary population of SDs 
typically emerges in the first 2 hours after the induction of 
focal ischemia, and a secondary SD cluster can generate 
with a peak frequency approximately 12 hours later (12). 
In the gyrencephalic cat brain, SDs were recorded to occur 
up to 14 hours (end point of experiments) after the onset 
of ischemia (13). Finally, clinical studies identified SDs up 
till 9 days after the surgical intervention for the alleviation 
of the primary injury (3,14). The experimental and clinical 
data together demonstrate that injury-related SDs first occur 
shortly after the primary ischemic insult and keep generat-
ing for a number of days to follow.
SD has long been suspected to aggravate ischemic injury. 
Indeed, the coincidence of SD evolution and infarct matu-
ration was demonstrated by a linear correlation between 
the total number or cumulative duration of recurrent SDs 
and the infarct volume, established after middle cerebral 
artery occlusion in rats (15,16). In subarachnoid hemor-
rhage patients, delayed ischemic neurological deficit corre-
sponded with a sequence of recurrent SDs (3). Further, the 
prolonged duration of SDs was related to the maturation of 
cortical lesions after traumatic brain injury (4). The relation-
ship between SD occurrence and injury progression appears 
causal because KCl-induced SDs invading the penumbra 
from remote sites increased infarct volumes in experimental 
stroke (17,18). Moreover, an experimental imaging study 
revealed that the site of SD elicitation gradually migrated 
from near the primary ischemic core to increasingly dis-
tant areas in the parietal cortex over a 4-hour monitoring 
period after middle cerebral artery occlusion in the rat (19). 
If SDs are triggered at the rim of an infarct, this observa-
tion indicates, indirectly, the growth of the infarcted area, 
probably by the conversion of penumbra to infarct. At tissue 
level, ischemia-induced SDs coincide with dendritic bead-
ing and loss of spines indicative of synaptic disintegration 
(20), and prolonged astroglial swelling leading to disturbed 
tissue homeostasis (21). In summary, experimental results 
show that SDs are involved in the progression of ischemic 
damage during the subacute phase of injury (22), whereas 
groundbreaking clinical studies have gathered evidence that 
clusters of prolonged SDs play a key role in delayed injuries 
and predict worse clinical outcome (3,4).
SDs are thought to initiate in the core or at the border of 
the ischemic focus in focal ischemia and propagate across 
tissue not yet infarcted (23–25). In global ischemic models, 
in which the definition of ischemic core becomes redun-
dant, the site of SD elicitation is suspected to fall in regions 
most susceptible for the ischemic insult, or undergoing the 
gravest perfusion deficit due to relatively low microvascular 
density or uneven perfusion (11). Accordingly, the deter-
mination of a flow threshold for SD elicitation is a relevant 
approach to identify conditions favorable for SD onset. 
The flow threshold was estimated as the lower range of the 
brain’s autoregulatory capacity in global ischemia (11) or 
defined accurately as being around 40 ml/g/min in focal 
ischemia (26). Yet, the ultimate, direct cause of SD elicita-
tion is the critical, elevated concentration of extracellular 
K+ and/or glutamate (7), both of which accumulate in the 
ischemic brain due to increased release from neural ele-
ments and altered clearance by astrocytes (27,28).
The duration of SD (ie, the time measured at half ampli-
tude between depolarization and repolarization) extends 
with the increasing severity of ischemia (1). Thus, at least 
three types of SD can be differentiated based on duration: (i) 
short transient SD, which persists from 20 seconds up to a 
few minutes; (ii) intermediate or prolonged SD, which may 
last as long as an ischemic flow reduction and be followed 
by repolarization synchronous with the recovery of local 
cerebral blood flow (CBF); and (iii) terminal SD, which is 
not followed by the restoration of resting membrane poten-
tial at any time later (1). The prolonged duration of SD 
indicates the insufficiency of membrane ion pumps to repo-
larize neurons (1) and is proposed to represent increasingly 
more severe injury to the brain tissue (4). Researchers agree 
that the cellular mechanisms corresponding with prolonged 
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SD include sustained intracellular calcium overload in 
neurons (20,29). Intracellular calcium accumulation syn-
chronous with glutamate release and n-methyl-d-aspartate 
receptor activation during SD would resemble excitotoxic 
events. Yet, no definitive consensus has been reached as to 
whether SD-related intracellular calcium load is depend-
ent on n-methyl-d-aspartate receptor activation though the 
most recent results support this concept (20,29,30).
SDs are currently believed to exacerbate ischemic 
brain injury via related atypical hemodynamic responses 
(Figure  1). In the rat, the physiological pattern of 
SD-associated CBF changes is composed of an initial, 
brief drop of CBF; a marked, transient hyperemia; and a 
sustained hypoperfusion also known as spreading oligemia 
(31,32). These three subsequent phases of the SD-related 
CBF response are assumed to be the result of a sequence 
and combination of separate vasoregulatory mechanisms 
(32,33). In man, the pattern of the SD-related CBF response 
has been acquired only in disease states, but comprehensive 
analysis and comparison of the CBF response in the rat and 
patients revealed a good correspondence (34). Hence, the 
characteristics of the CBF response in the rat are assumed 
to be applicable for man, and data obtained from rat mod-
els are regarded highly relevant for human disease states. 
Similar to physiological neuronal activation, the evolving 
functional hyperemia induced by SD supplies the brain 
tissue with energy substrates to be used by ion exchange 
pumps for the restoration of resting membrane potential.
The SD-related CBF response shows diverse kinetics 
in animal models of cerebral ischemia: (i) the hyperemic 
element may be suppressed; (ii) the initial CBF drop and 
the spreading oligemic phase of the response may become 
undetectable, leaving only an obvious hyperemic compo-
nent visible on the CBF recording; (iii) all three elements 
of the CBF response may remain obscure; or (iv) the CBF 
response may develop as hypoemia rather than hyperemia 
with a particular SD (11,35–39). The reversed CBF response 
has become known as spreading ischemia and is considered 
as a result of inverse neurovascular coupling (1). A  wide 
spectrum of ischemic SD-related CBF responses were 
acquired in patients ranging from dominating hyperemia 
to prolonged cortical spreading ischemia with intermedi-
ate forms characterized by biphasic (hypoemic–hyperemic) 
responses (40,41).
The vasoregulatory mechanisms that modulate the pattern 
of CBF responses during ischemia are complex. The normal 
hemodynamic response to SD is achieved by a fine balance 
between constrictive and dilator vasoregulatory mechanisms 
(33). Ischemia alters the baseline tone of arteries: shortly 
after the occlusion of a cerebral vessel, vasodilation evolves 
distal to the site of occlusion as an autoregulatory response 
to maintain CBF against decreasing perfusion pressure. This 
leads to maximal vasodilation and exhausts microvascu-
lar reserve capacity. Days after the primary injury, vasos-
pasm may develop, which is implicated in delayed cerebral 
ischemia after subarachnoid hemorrhage (42). In addition 
to the shift in baseline vascular tone, ischemia also causes 
endothelial cell dysfunction (43), thereby compromising 
specific elements of vascular reactivity. A  combination 
of adjusted baseline tone and impaired vascular reactivity 
during ischemia may set the scene for dominating vasocon-
striction, which may account for hampered hyperemia, or 
spreading ischemia with SD. Vasoconstriction may prevail 
because local vasoconstrictive mediation becomes accen-
tuated or because counteracting vasodilators that would 
normally balance out vasoconstriction are not available. 
Experimental evidence for both options have been gathered. 
As such, vasoconstrictive mediation in response to electrical 
field stimulation was shown in brain slices derived from rats 
with experimental subarachnoid hemorrhage. The vasocon-
strictor stimulus was identified as perivascular K+ concen-
tration increased above the dilation/constriction threshold 
(20 mM). The excessive extracellular K+ accumulated as the 
result of efflux from astrocytes via large-conductance Ca2+-
activated K+ channels (44). On the other hand, as an exam-
ple for the role of counteracting vasodilators, the presence 
of nitric oxide (nO) mediated vasodilation of the isolated 
middle cerebral artery in the face of elevated extracellular 
K+ concentration typical of SD, whereas vasoconstriction 
developed in the absence of nO (45). A corresponding in 
vivo study identified nO scavenging (eg, by hemoglobin) 
as the mechanism limiting nO availability and thereby cre-
ating vasoconstrictive CBF response to SD (36). Disabled 
vasodilation may also uncover the effect of vasoconstrictive 
prostanoids, which were proposed to mitigate the SD-related 
vasodilation in the intact brain (46).
The pattern of CBF response associated with a particular 
SD is not conserved through the course of SD propagation 
but can change as the same SD travels across areas with vary-
ing severity of ischemia. For example, CBF response was 
hypoemic in the vicinity of the ischemic core but transformed 
into hyperemia with the increasing distance from the core in 
animal models of cerebral ischemia and in patients with malig-
nant stroke (37,38,41). These results imply that the metabolic 
consequences of an SD must be most harmful when the site 
of SD elicitation is in close proximity to the ischemic core.
The hyperemic types of CBF responses coupled with 
ischemic SDs may not be necessarily harmful, but under 
specific conditions, they are suggested not to satisfy the 
metabolic demand of the tissue and aggravate metabolic 
supply–demand mismatch (Bere et  al., unpublished data, 
2014)  (Figure 1). The injurious nature of the CBF response 
may lie in deficient vascular reactivity following SD occur-
rence: vasodilation that typically evolves in response to 
hypercapnia, acidosis, and increasing K+ concentration 
is severely impaired for hours after the passage of an SD 
(47–49). In an ischemic environment, such prolonged vaso-
motor dysfunction may prevent the evolution of proper vas-
odilation to arising stimuli and thereby become deleterious 
for the survival of nervous tissue that is already challenged.
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In addition, hyperemic CBF responses may impose cer-
ebrovascular steal in the ischemic region (Figure  1): the 
hyperemic response may mobilize arterial blood destined to 
supply more severely hypoperfused territories, thereby fur-
ther depriving those territories of oxidative substrates (50). 
This process would cause injury remote to the site of the 
hyperemic response itself.
Finally, spreading ischemia is the most harmful type of 
CBF response as it is proposed to maintain a vicious cycle 
of sustained neuronal depolarization, persistent release of 
vasoconstrictors, and fatal tissue adenosine triphosphate 
depletion (1). This concept is supported by the observation 
that the extent of cortical area with deep perfusion deficit 
increased with each successive SD in the rat brain (Clark 
et al., accepted for publication, 2014) (25). Ultimately, SDs 
with such CBF responses inevitably cause damage to the 
tissue (37). The above cascade of events is particularly rel-
evant for the maturation of brain infarcts at the expense of 
the penumbra in ischemic injury (22).
Experimental and clinical observations thus demon-
strate convincingly that spontaneous SDs regularly occur 
in ischemia and are often coupled with atypical hemody-
namic responses, which impose irrevocable damage to the 
ischemic nervous tissue.
Age Alters the Typical Features of Spreading 
Depolarization: Implications for Ischemic 
Brain Injury
Even though stroke may occur in any phase of life, aging 
emerges as the most important independent risk factor for 
the incidence and prevalence of ischemic stroke (51,52). 
Aging also significantly predicts poor patient outcomes 
(52). The impact of age on stroke pathophysiology has been 
the target of intensive research in order to understand the 
reason for the increased susceptibility of the aged brain to 
stroke-related injury; yet, the potential contribution of SD 
has remained largely unexplored.
As an obvious approach to reveal the influence of aging of 
stroke pathophysiology, the infarct volume after experimen-
tal cerebral vessel occlusion was estimated and compared in 
young adult (2–4 months) and aging (9–24 months) rodents 
(52). Aged females consistently had worse stroke outcomes 
than their young counterparts, whereas studies utilizing 
male animals remained inconclusive in this respect (52). 
Still, older mice invariably exhibited more severe neuro-
logical impairments and significantly higher mortality rates 
irrespective of infarct volume (53). Infarct development 
and neuronal degeneration early after transient middle cer-
ebral artery occlusion were accelerated in old rats compared 
with their young counterparts (54), and the conversion of 
penumbra into infarction increased with advancing age in 
patients (55). SD facilitates early infarct development and 
the conversion of the penumbra to infarct, but very few 
studies exist that investigated (i) whether age alters SD 
evolution and (ii) whether a potential age-specific pattern 
of SD would contribute to—or at least coincide with—the 
age-related intensification of infarct development. Such 
studies would be timely because clinical SD research has, 
now, achieved the reliable identification of SD events and 
associated hemodynamic variations in patients.
We have found in rat models that the advancement of 
age reduces the frequency of K+-induced recurrent SDs 
and increases the latency between subsequent SD events 
(56). In addition, the rate of SD propagation decreased with 
increasing age, and SDs failed to propagate longer distances 
frequently in the aged compared with the young rat brain 
(57). The susceptibility of the brain to SD may be deter-
mined by several features of the gray matter’s biochemistry 
and cytoarchitecture (eg, volume of the interstitial space 
and maturation of neurotransmitter systems) that undergo 
adaptational changes during aging (7).
Figure 1. Conceptual cascade of events that lead to various types of hemodynamic response and tissue outcome associated with spreading depolarization. note 
that aging sets the scene for the higher incidence of adverse cerebral blood flow (CBF) patterns. 
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Similar to K+-induced SDs, the number of spontane-
ous SDs during transient focal ischemia was lower in aged 
rats (Clark et al., accepted for publication, 2014). A clini-
cal study that identified SDs after acute brain injury also 
reported a higher incidence of SD in young compared with 
older patients (58). Taken together, the aging brain appears 
to be less susceptible for SD elicitation. nevertheless, the 
ratio of prolonged SDs of all SDs recorded in the ischemic 
penumbra was found considerably higher in old than in 
young rats (54% and 7%, respectively), and the cortical sur-
face involved in the propagation of prolonged SDs tripled 
in old rats with respect to their young counterparts (Clark 
et  al., accepted for publication, 2015). All things consid-
ered, the threshold to trigger SDs is higher in the aging 
brain, but once elicited during ischemia, SDs are persistent 
and their long duration may indicate metabolic crisis. This 
may accelerate infarct maturation or extend the volume of 
infarct in the aging brain.
The deleterious effect of SD is widely attributed to the 
associated CBF response, the pattern of which may also 
alter with advancing age. As such, the magnitude of the dis-
tinct elements of the CBF response was found to decrease 
in rats and in a transgenic mouse model of human cerebral 
amyloid angiopathy with normal aging (56,59). In addition, 
the hyperemic component in rats developed at a signifi-
cantly lower rate with age (56), and spreading ischemia—
in contrast with spreading hyperemia—appeared in the 
ischemic penumbra with a significantly higher incidence in 
old compared with young rats, which coincided with the 
prevalence of prolonged SDs (Clark et  al., accepted for 
publication, 2014). These results infer that attenuated or 
reversed SD-coupled CBF response is more probable in the 
aging brain. Because spreading ischemia appears to have a 
higher incidence in the aged ischemic brain (Clark et  al., 
accepted for publication, 2014) and the perfusion deficit 
after the onset of ischemia was shown to worsen in a step-
wise fashion with each successive spreading ischemic epi-
sode (37), the aging ischemic brain is suggested to be at an 
increased risk for SD-related injury.
Aging, interacting with pathophysiological events, has 
a paramount impact on the microvasculature, including 
exacerbated endothelial damage and blood–brain barrier 
disruption (60,61).The SD-related CBF response weakens 
or more frequently inverts in the ischemic penumbra with 
aging, possibly because aging reorganizes the microvascular 
architecture unfavorably or renders the cerebral vasoregula-
tory mechanisms less efficient or compromised (Figure 2). 
It is a prevailing hypothesis supported by experimental and 
clinical evidence that the arrangement of native collaterals 
(ie, vessels that exist before an ischemic insult) or effec-
tive cerebrovascular remodeling following ischemic injury 
may define the fate of the penumbra (62,63). Consequently, 
inadequate collateral CBF must be an important determi-
nant of infarct growth (64). Indeed, insufficient collateral 
reserve was shown to contribute to adverse tissue outcome 
observed in elderly patients of ischemic stroke (65). Further, 
experimental data demonstrated that the number and diam-
eter of native collaterals connecting the middle and anterior 
cerebral artery trees were significantly lower in aged com-
pared with young mice (66). In addition, collateral remod-
eling after middle cerebral artery occlusion was impaired 
in the aging ischemic mouse brain, resulting in increased 
infarct volume (66). SD would normally initiate vasodila-
tion and mobilize reserve blood for the hyperemic response 
to develop. The rarefaction of collaterals in the penumbra 
intensified by aging as described earlier may serve as a 
potential underlying structural basis for attenuated hyper-
emic CBF responses to SDs (Figure 2).
Aging inflicts functional impairment of the cerebral vascu-
lature as well, which may play a role in the deterioration of 
the SD-related flow response in the aging ischemic brain. For 
example, the magnitude of functional hyperemia evoked by 
whisker stimulation was markedly attenuated in aging mice, 
and the CBF increase induced by the topical application of 
the vasodilators acetylcholine or bradykinin also weakened 
(67). Further, the reduced vascular reactivity to acetazola-
mide challenge after internal carotid artery occlusion was 
more obvious in aged than in young mice (68). These func-
tional alterations were associated with vascular and neuronal 
oxidative stress because scavengers of reactive oxygen spe-
cies prevented the attenuation of the CBF response (67). The 
above results on cerebrovascular reactivity suggest that com-
promised vasodilation caused by oxidative stress may also be 
involved in the reduced magnitude of the SD-coupled hyper-
emia in the aging brain (Figure 2).
Focusing on spreading ischemia, an elegant in vitro study 
demonstrated that at elevated extracellular K+ concentration 
typical of SD, the presence of nO mediated vasodilation of 
the isolated middle cerebral artery, whereas vasoconstric-
tion developed in the absence of nO (45). Based on these 
results, the bioavailability of nO appears to be a decisive 
Figure 2. Aging and ischemia impose structural and functional alterations in 
the cerebrovascular network. The additive impact of these processes is suggested 
to contribute to the evolution of injurious cerebral blood flow (CBF) responses 
coupled to spreading depolarization. 
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condition for the shift to spreading ischemia in the face of 
an extracellular ionic milieu typical of SD. There is no con-
clusive evidence that nO synthase expression is hampered 
in the aging brain (69,70), but increased free radical produc-
tion restricts nO availability in old rats, which causes dys-
functional nO-based vasodilation (70,71). This age-related 
pathophysiological process, in combination with elevated 
extracellular K+ concentration in the ischemic penumbra, 
offers an explanation for the higher incidence of spreading 
ischemia in aged rats.
Besides the contribution of vascular elements of the neu-
rovascular unit to the modulation of the SD-related CBF 
response, the role of astrocytes in the process deserves con-
sideration. Astrocytes depolarize with SD and are heavily 
involved in K+ buffering during SD (7). Moreover, astrocytes 
control local CBF, via selective increase of Ca2+ concentra-
tion in astrocytic endfeet and related efflux of K+ through 
various types of K+ channels (28,72,73). Oscillatory eleva-
tion of intracellular Ca2+ in astrocytes was suggested to be a 
response to glutamate (74), which is released at high concen-
tration during SD and ischemia. Increased glutamate recep-
tor stimulation may contribute to the elevating magnitude of 
spontaneous astrocytic Ca2+ oscillations, which was proposed 
to lead to K+-dependent inverse neurovascular coupling in 
response to electrical field stimulation observed after suba-
rachnoid hemorrhage (44). The aging process alters astro-
cyte function unfavorably and accelerates injury-induced 
astrocyte reactivity (75). This may conceivably impact on 
the astrocyte-based vasoregulation and contribute to compro-
mised CBF responses to SD in the aging, ischemic brain.
In summary, the structural and functional changes of 
the cerebrovascular network that occur during aging are 
postulated to predispose the microvasculature to atypical 
CBF responses with SD. This, in turn, is suggested to pose 
a higher risk for the incidence of SD-related injury in the 
aging brain.
Are Age-Related Changes in SD Evolution 
Relevant for Other Neurological Disease 
States?
Migraine is a common neurovascular disorder. Migraine 
often occurs for the first time between 15 and 24 years of 
age, is most common in the 35 to 40 age group, and is known 
to decrease in frequency and severity with advancing age 
(76). About a quarter of all migraines is associated with aura 
that appears shortly before or during the progression of a 
migraine headache. It has been long contemplated that SD 
is involved in the pathophysiology of migraine with aura 
(8,31). More specifically, the aura is thought to be initiated by 
the elicitation of SD in the visual cortex, the propagation of 
which coincides with the expansion of the visual symptoms 
(scintillation-scotoma) (77). Moreover, the propagation of 
the long-lasting oligemic component of the CBF response to 
SD can be identified by single photon emission tomography 
in patients with migraine with aura (78). According to the 
theory, the ventral spreading of SD causes activation of pain-
sensitive fibers and related development of headache (31).
The experimental evidence collected here demonstrates 
that the aging but otherwise intact brain becomes less sus-
ceptible for SD elicitation and propagation (56,57). This 
appears to coincide with the clinical data that migraine 
headaches become less frequent and severe with advanc-
ing age and often cease after the age of 50–60 years. The 
evaluation of this thought-provoking relationship is highly 
complicated by the fact that genetic factors and hormonal 
fluctuations are known to influence the development of 
both migraine and SD (79–81). Still, the careful, compre-
hensive examination of the relationship between SD, aging, 
and migraine with aura would help dissecting processes 
involved in the evolution of migraine, with the ultimate goal 
to design effective therapy.
Conclusion
The summary of the available experimental data demon-
strates that aging has a marked impact on SD evolution and 
corresponding changes in CBF. The presented overview of 
the field of research has led to the hypothesis that an age-
specific pattern of the SD-associated CBF response must 
be involved in augmenting the expansion of ischemic brain 
damage in the elderly patients. We propose that structural 
and functional (mal)adaptation of the cerebrovascular sys-
tem with aging serves as a potential basis for compromised 
vascular reactivity and subsequent tissue damage. The pro-
cess may be relevant for the extension of brain infarcts in 
the subacute and delayed phases after a primary episode of 
stroke. The concept put forward mainly relies on initial data 
derived from experimental SD research, and may stimulate 
further investigation to achieve a comprehensive overview 
of the implication of SD in injury progression in the aged 
brain.
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